Nikko Asset Management Americas Inc. boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 501,977 shares of the company’s stock after buying an additional 47,455 shares during the […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $8.63, but opened at $9.00. Recursion Pharmaceuticals shares last traded at $9.18, with a volume of 293,828 shares changing hands. Wall Street Analysts Forecast Growth RXRX has been the topic of a […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) CEO Christopher Gibson sold 33,073 shares of the firm’s stock in a transaction dated Wednesday, May 3rd. The stock was sold at an average price of $4.71, for a total transaction of $155,773.83. Following the sale, the chief executive officer now directly owns 953,225 shares in the company, […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the firm’s stock in a transaction dated Tuesday, April 18th. The shares were sold at an average price of $5.93, for a total transaction of $52,688.05. Following the transaction, the director now directly owns 7,558,517 shares in the company, valued at […]